iCoreConnect Inc. Announces Agreement to Divest MSP Division to T20 in an Asset Sale, Expecting to Deliver Strategic and Financial Advantages for Investors

Stock Information for Eagle Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Eagle Pharmaceuticals Inc.

iCoreConnect Announces Reverse Stock Split
iCoreConnect Partners With The Dental Marshal to Bring Cloud Software Solutions to Client Dentists
The Maryland State Dental Association Expands Endorsement to Include iCoreConnect's Full Platform of Products
iCoreConnect Achieves Robust Revenue Growth in Q3 With Expanding Customer Base
North Dakota Dental Association Endorses iCoreConnects Comprehensive Product Platform
iCoreConnect Announces Expansion of Endorsement With The Arizona Dental Association (AzDA)
Delaware State Dental Society Endorses Five iCoreConnect Products
iCoreConnect Inc. Announces Strategic Acquisition of Healthcare Circle of Excellence Assets

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.